By stimulating thrombolysis and rescuing the ischemic brain via reopening occluded vessels, intravenous administration of recombinant tissue plasminogen activator (t-PA) remains the most effective intervention with FDA approval for emergency treatment of stroke (Whiteley et al., 2014). Here, PLAT is linked to stroke disorder.